10 Yuan-Hao Lee et al.
matory responses induced by ischemia ⁄ reperfusion, platelet-
activating factor, or oxidants. Free Radic. Biol. Med. 34, 810–817.
18. Losa, G. A. (2003) Resveratrol modulates apoptosis and oxidation
in human blood mononuclear cells. Eur. J. Clin. Invest. 33, 818–823.
19. Yen, G. C., P. D. Duh and C. W. Lin (2003) Effects of resveratrol
and 4-hexylresorcinol on hydrogen peroxide-induced oxidative
DNA damage in human lymphocytes. Free Radic. Res. 37, 509–514.
20. Ahmad, A., F. A. Syed, S. Singh and S. M. Hadi (2005) Prooxi-
dant activity of resveratrol in the presence of copper ions: Muta-
genicity in plasmid DNA. Toxicol. Lett. 159, 1–12.
21. Gatz, S. A. and L. Wiesmuller (2008) Take a break—Resveratrol
in action on DNA. Carcinogenesis 29, 321–332.
22. Roemer, K. and M. Mahyar-Roemer (2002) The basis for the
chemopreventive action of resveratrol. Drugs Today (Barc) 38,
571–580.
23. Ali, M. S., S. A. Ibrahim, S. Jalil and M. I. Choudhary (2007)
Ursolic acid: A potent inhibitor of superoxides produced in the
cellular system. Phytother. Res. 21, 558–561.
24. Najid, A., A. Simon, J. Cook, H. Chable-Rabinovitch, C. Delage,
A. J. Chulia and M. Rigaud (1992) Characterization of ursolic
acid as a lipoxygenase and cyclooxygenase inhibitor using mac-
rophages, platelets and differentiated HL60 leukemic cells. FEBS
Lett. 299, 213–217.
25. Yin, M. C. and K. C. Chan (2007) Nonenzymatic antioxidative
and antiglycative effects of oleanolic acid and ursolic acid.
J. Agric. Food Chem. 55, 7177–7181.
26. Balanehru, S. and B. Nagarajan (1991) Protective effect of ole-
anolic acid and ursolic acid against lipid peroxidation. Biochem.
Int. 24, 981–990.
be achieved by the synthesis of chemical derivatives with
superior systemic uptake and distribution, a route currently
being explored commercially. Until such agents are available,
it is likely that regular nutritional intake of these compounds
will be the most practical way to obtain whatever beneficial
effect on ocular health is conferred by the low systemic
concentrations achieved via dietary sources.
Acknowledgements—This work has been supported in part by the
RMG Research Endowment, a grant from the Julio Palmaz Endow-
ment in the Department of Radiology at the UTHSCSA (Y-HL) and a
grant from the University of Texas System ⁄ San Antonio Life Sciences
Institute (RDG). Y-HL was supported by National Science Founda-
tion Partnerships for Research and Education in Materials (PREM)
Grant No. DMR-0934218 in collaboration with Northwestern
University MRSEC.
REFERENCES
1. Hillenkamp, F. (1989) Laser radiation tissue interaction. Health
Phys. 56, 613–616.
2. Jacques, S. L. (1997) Laser-tissue interactions. In Non-Ionizing
Radiation: An Overview of the Physics and Biology (Edited by K.
Hardy, M. Meltz and R. D. Glickman), pp. 81–98. Medical
Physics Publishing, Madison,WI.
27. Shishodia, S., S. Majumdar, S. Banerjee and B. B. Aggarwal
(2003) Ursolic acid inhibits nuclear factor-kappaB activation
induced by carcinogenic agents through suppression of IkappaB-
alpha kinase and p65 phosphorylation: Correlation with
down-regulation of cyclooxygenase 2, matrix metalloproteinase 9,
and cyclin D1. Cancer Res. 63, 4375–4383.
28. Mohan, S., K. Koyoma, A. Thangasamy, H. Nakano, R. D.
Glickman and N. Mohan (2007) Low shear stress preferentially
enhances IKK activity through selective sources of ROS for per-
sistent activation of NF-kappaB in endothelial cells. Am. J.
Physiol. Cell Physiol. 292, C362–C371.
29. Pahl, H. L. (1999) Activators and target genes of Rel ⁄ NF-kappaB
transcription factors. Oncogene 18, 6853–6866.
30. Raju, U., G. J. Gumin and P. J. Tofilon (2000) Radiation-induced
transcription factor activation in the rat cerebral cortex. Int. J.
Radiat. Biol. 76, 1045–1053.
3. Glickman, R. D. (2002) Phototoxicity to the retina: Mechanisms
of damage. Int. J. Toxicol. 21, 473–490.
4. Sliney, D. H. (2005) Exposure geometry and spectral environment
determine photobiological effects on the human eye. Photochem.
Photobiol. 81, 483–489.
5. Taylor, H. R., B. Munos, S. West, N. M. Bressler, S. B. Bressler
and F. S. Rosenthal (1990) Visible light and risk of age-related
macular degeneration. Trans. Am. Ophthalmol. Soc. 88, 163–178.
6. Tomany, S. C., K. J. Cruickshanks, R. Klein, B. E. Klein and M.
D. Knudtson (2004) Sunlight and the 10-year incidence of
age-related maculopathy: The Beaver Dam Eye Study. Arch.
Ophthalmol. 122, 750–757.
7. Cabrera, M. P. and R. H. Chihuailaf (2011) Antioxidants and the
integrity of ocular tissues. Vet. Med. Int. 2011, 905153 (pp. 1–8).
8. Kelsey, N. A., H. M. Wilkins and D. A. Linseman (2010)
Nutraceutical antioxidants as novel neuroprotective agents.
Molecules 15, 7792–7814.
31. Vile, G. F., A. Tanew-Ilitschew and R. M. Tyrrell (1995) Activation
of NF-kappa B in human skin fibroblasts by the oxidative stress
generated by UVA radiation. Photochem. Photobiol. 62, 463–468.
32. Li, N. and M. Karin (1998) Ionizing radiation and short wave-
length UV activate NF-kappaB through two distinct mechanisms.
Proc. Natl Acad. Sci. USA 95, 13012–13017.
9. Baur, J. A. and D. A. Sinclair (2006) Therapeutic potential of res-
veratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5, 493–506.
10. Das, D. K. and N. Maulik (2006) Resveratrol in cardioprotection:
A therapeutic promise of alternative medicine. Mol. Interv. 6, 36–
47.
33. Glickman, R. D., M. Natarajan, B. A. Rockwell, M. Denton, S.
Maswadi, N. Kumar and F. Nieves-Roldan (2005) Intracellular
signaling mechanisms responsive to laser-induced photochemical
and thermal stress. In Optical Interactions with Tissue and Cells
XVI (Edited by S. L. Jacques and W. P. Roach), Proc. SPIE 5695,
260–269.
34. Legrand-Poels, S., S. Schoonbroodt, J. Y. Matroule and J. Piette
(1998) NF-kappa B: An important transcription factor in photo-
biology. J. Photochem. Photobiol. B, Biol 45, 1–8.
35. Yim, E. K., K. H. Lee, S. E. Namkoong, S. J. Um and J. S. Park
(2006) Proteomic analysis of ursolic acid-induced apoptosis in
cervical carcinoma cells. Cancer Lett. 235, 209–220.
36. Yim, E. K., M. J. Lee, K. H. Lee, S. J. Um and J. S. Park (2006)
Antiproliferative and antiviral mechanisms of ursolic acid and
dexamethasone in cervical carcinoma cell lines. Int. J. Gynecol.
Cancer 16, 2023–2031.
11. Gehm, B. D., J. M. McAndrews, P. Y. Chien and J. L. Jameson
(1997) Resveratrol, a polyphenolic compound found in grapes and
wine, is an agonist for the estrogen receptor. Proc. Natl Acad. Sci.
USA 94, 14138–14143.
12. Klinge, C. M., K. E. Risinger, M. B. Watts, V. Beck, R. Eder and
A. Jungbauer (2003) Estrogenic activity in white and red wine
extracts. J. Agric. Food Chem. 51, 1850–1857.
13. Turner, R. T., G. L. Evans, M. Zhang, A. Maran and J. D. Sib-
onga (1999) Is resveratrol an estrogen agonist in growing rats?
Endocrinology 140, 50–54.
14. Basly, J. P., F. Marre-Fournier, J. C. Le Bail, G. Habrioux and A.
J Chulia (2000) Estrogenic ⁄ antiestrogenic and scavenging prop-
erties of (E)- and (Z)-resveratrol. Life Sci. 66, 769–777.
15. Sato, M., G. Maulik, D. Bagchi and D. K. Das (2000) Myocardial
protection by protykin, a novel extract of trans-resveratrol and
emodin. Free Radic. Res. 32, 135–144.
37. Huang, M. T., C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K.
Stauber, W. Ma, C. Georgiadis, J. D. Laskin and A. H. Conney
(1994) Inhibition of skin tumorigenesis by rosemary and its con-
stituents carnosol and ursolic acid. Cancer Res. 54, 701–708.
38. Tokuda, H., H. Ohigashi, K. Koshimizu and Y. Ito (1986)
Inhibitory effects of ursolic and oleanolic acid on skin tumor
16. Sato, M., P. S. Ray, G. Maulik, N. Maulik, R. M. Engelman, A. A.
Bertelli, A. Bertelliand and D. K. Das (2000) Myocardial protection
with red wine extract. J. Cardiovasc. Pharmacol. 35, 263–268.
17. Shigematsu, S., S. Ishida, M. Hara, N. Takahashi, H. Yoshimatsu,
T. Sakata and R. J. Korthuis (2003) Resveratrol, a red wine
constituent polyphenol, prevents superoxide-dependent inflam-